FDA Drug Approvals
New drug approvals announced by the U.S. Food and Drug Administration, updated daily from the FDA press feed.
Updated 2026-09-08
| Date | Announcement | Type |
|---|---|---|
| 2026-09-04 | FDA Grants Accelerated Approval to a New Breast Cancer Treatment | Accelerated approval |
| 2026-09-03 | FDA Approves First Drug to Treat Alexander Disease | Approval |
| 2026-08-28 | FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder | Approval |
| 2026-08-27 | FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults | Approval |
| 2026-08-26 | FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer | Approval |
| 2026-08-19 | FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia | Approval |
| 2026-08-06 | FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma | Approval |
| 2026-08-05 | FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms | Approval |
What changed
- 2026-09-08: First publication. Table seeded with the current approval announcements in the FDA press feed.
Compiled from public sources; every announcement links to the FDA press release. This page is general information, not medical advice, and it is not a substitute for individual care.